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Mutation of the metabotropic glutamate receptor type 7 (mGlu7) induces absence-like
epileptic seizures, but its precise role in the somatosensory thalamocortical network
remains unknown. By combining electrophysiological recordings, optogenetics, and
pharmacology, we dissected the contribution of the mGlu7 receptor at mouse thalamic
synapses. We found that mGlu7 is functionally expressed at both glutamatergic and
GABAergic synapses, where it can inhibit neurotransmission and regulate short-term
plasticity. These effects depend on the PDZ-ligand of the receptor, as they are lost
in mutant mice. Interestingly, the very low affinity of mGlu7 receptors for glutamate
raises the question of how it can be activated, namely at GABAergic synapses
and in basal conditions. Inactivation of the receptor activity with the mGlu7 negative
allosteric modulator (NAM), ADX71743, enhances thalamic synaptic transmission. In
vivo administration of the NAM induces a lethargic state with spindle and/or spike-
and-wave discharges accompanied by a behavioral arrest typical of absence epileptic
seizures. This provides evidence for mGlu7 receptor-mediated tonic modulation of
a physiological function in vivo preventing synchronous and potentially pathological
oscillations.
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INTRODUCTION
G protein-coupled receptors (GPCRs) represent the largest family of membrane receptors in
mammals and are involved in a big diversity of patho-physiological conditions. These receptors can
display constitutive (agonist-independent) activity, and mutations leading to constitutively active
GPCR receptors ex vivo have been linked to several human diseases (de Ligt et al., 2000). However,
only few reports exist on the role of constitutively active wild-type (WT) receptors in their natural
environment, in vitro and in vivo (Meye et al., 2014). For instance, constitutive activity of native H3
receptors can control rat histaminergic neurons in vivo (Morisset et al., 2000), while constitutively
active dopamine, opioid, and serotonin receptors are expressed in the brain reward system (Meye
et al., 2014).
Among eight genes coding for metabotropic glutamate receptors (mGlu1-8), several studies
have investigated the effects of negative allosteric modulation of WT mGlu1 and mGlu5 in neurons
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(Prezeau et al., 1996; Ango et al., 2001) and in vivo (Rodriguez
et al., 2010; Keck et al., 2012), while much less is known
about the constitutive activity of the other mGluRs. In the
mammalian CNS, the mGlu7 receptor gene shows the highest
degree of evolutionary conservation across species. It is the
most widely distributed in a broad range of synapses critical
for both normal CNS function as well as psychiatric and
neurological disorders including anxiety, depression, obsessive–
compulsive disorders, and schizophrenia (Hamilton, 2011; Shyn
et al., 2011; Park et al., 2013). Different splice mGlu7 variants (a–
e) exist, with mGlu7a being the predominantly expressed variant
(Flor et al., 1997; Schulz et al., 2002). The mGlu7a receptor
is expressed at glutamatergic presynaptic terminals (Bradley
et al., 1998; Kinoshita et al., 1998), where its association to the
PDZ-protein PICK1 mediates the inhibition of voltage-gated
calcium channels and, as a result, a decrease in neurotransmitter
release (Perroy et al., 2000, 2002; Millán et al., 2002). The
activation of mGlu7 receptors remains a puzzling issue, due
to its very low affinity for glutamate (in the millimolar range,
amongst the lowest for neurotransmitters). Such glutamate
concentration might be reached in the glutamatergic synaptic
cleft upon intense neuronal activity (Cartmell and Schoepp,
2000; Pelkey et al., 2005). Intriguingly, mGlu7 receptors are
also expressed at GABAergic presynaptic sites in hippocampus
(Somogyi et al., 2003), hypothalamus (Schrader and Tasker,
1997), and somatosensory cortex (Dalezios et al., 2002) where
the dearth of glutamate highlights the enigma of mGlu7 receptor
activation and function in physiological conditions.
The mGlu7 receptor knockout mouse displays impaired fear
response and higher susceptibility to alcohol and convulsants
(Sansig et al., 2001; Goddyn et al., 2008). The knock-in (KI)
AAA mutation of the exon coding for the mGlu7a C-terminal
PDZ ligand (here named mGlu7aAAA mouse) suppresses the
receptor interaction with the PDZ protein PICK1. Blockade of
this interaction has consequences on the receptor downstream
signaling and results in loss of agonist-dependent inhibition of
synaptic transmission (Perroy et al., 2002). This is sufficient to
induce spatial working memory deficits (Zhang et al., 2008) and
to trigger spontaneous absence-like epileptic seizures (Bertaso
et al., 2008), suggesting a crucial role of mGlu7a to control
neuronal network activity. We focused our attention on the
thalamic circuitry responsible for absence epileptic seizures,
characterized by a hypersynchronous oscillatory activity of
thalamic and cortical neurons, leading to typical spike-and-wave
discharges (SWD) of the thalamocortical (TC) loop in human
and animal models (Crunelli and Leresche, 2002). Seizures
involve reciprocal projections between two thalamic nuclei,
the GABAergic reticular nucleus (TRN) and the glutamatergic
ventro-postero-medial nucleus (VPM), and the somatosensory
(barrel) cortex (Figure 1A) (Crunelli and Leresche, 2002;
Steriade, 2006; Huguenard and McCormick, 2007; Beenhakker
and Huguenard, 2009).
The lack of specific pharmacological tools has long been a
critical impairment for the study of mGlu7 receptor function.
Here, using a brain-penetrant negative allosteric modulator
(NAM), ADX7174, which displays high specificity and affinity for
the mGlu7 receptor (Kalinichev et al., 2013), together with a more
classical orthosteric agonist (D,L-AP4) and a mouse KI mutant
for mGlu7 (mGlu7aAAA mouse), we revisited the function of
this receptor in vitro and in vivo. We studied the functional
distribution of the mGlu7a receptor in thalamic synapses in WT
and mGlu7aAAA mice, comparing electrically and optogenetically
evoked postsynaptic responses, in vivo electroencephalography
(EEG) and behavioral analysis. Our data provide evidence
for mGlu7 tonic activity in vivo, which occurs at specific
glutamatergic and GABAergic synapses of the thalamocortical
circuitry, resulting in persistent modulation of the network
activity and animal vigilance state.
MATERIALS AND METHODS
ADX71743 Synthesis
ADX71743 was synthesized according to the following scheme
(Contour et al., 2007):
(E)-4-(2,4-dimethylphenyl) but-3-en-2-one (1) (El-Batta et al.,
2007).
To a solution of 2,4-dimethylbenzaldehyde (500 mg,
3.73 mmol, 1 eq) in methanol/water 1:1 (8 ml) was added
1-triphenyl-phosphoranylidene-2-propanone (1.2 g, 3.73 mmol,
1 eq) and the mixture was refluxed for 2 h. After cooling, the
solvent was removed under reduced pressure. The residue
was extracted with dichloromethane (3∗50 ml). The combined
organic layers were dried over magnesium sulfate, filtered and
concentrated under vacuum. The crude was chromatographed
on a silicagel column with cyclohexane/ethyl acetate (85:15) to
afford 1 as a slightly yellow oil (613.6 mg, 3.53 mmol, 94.5%).
TLC: Rf= 0.47 (cyclohexane/ethyl acetate 8:2, UV).
1H NMR (500 MHz, CDCl3): δ 2.21 (s, 3H), 2.25 (s, 3H),
2.28 (s, 3H), 6.50 (d, J = 16.2 Hz, 1H), 6.89 (s, 1H), 6.90 (d,
J = 8.2 Hz, 1H), 7.34 (d, J = 8.2 Hz, 1H), 7.67 (d, J = 16.2 Hz,
1H).
13C NMR (126 MHz, CDCl3): δ 19.2, 20.9, 27.2, 126.0, 126.6,
126.9, 130.1, 131.3, 137.4, 140.1, 140.2, 197.6.
MS (ESI): m/z 175.2 [M+H]+
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5-(2,4-dimethylphenyl)cyclohexane-1,3-dione (2) (Courtney
et al., 2008).
To a solution of 1 (4.36 g, 25 mmol, 1 eq) in dry ethanol
(20 ml) was added NaOEt (21% in ethanol; 19.4 ml, 0.127 mol,
5 eq) and diethylmalonate (3.9 ml, 25 mmol, 1 eq) under
stirring. The mixture was stirred at refluxed for 1 h 30 min. The
reaction mixture was cooled to ambient temperature. An aqueous
solution of sodium hydroxide (2 M, 20 ml) was added to the
reaction mixture, which was heated at 80◦C for 3 h. Ethanol in
excess was removed by evaporation. The mixture was acidified
with concentrated HCl (20 ml) and the reaction mixture was
refluxed for 3 h 30′ and left to cool to ambient temperature. The
compound was extracted with ether (3∗200 ml). The combined
organic layers were dried over magnesium sulfate, filtered and
concentrated under vacuum. The crude was chromatographed
on a silicagel column with dichloromethane/ethyl acetate (6:4) to
afford a pale yellow oil (2) (4.1 g, 19 mmol, 75.6%).
TLC: Rf= 0,46 (dichloromethane/ethyl acetate 85:15, UV).
1H NMR (250 MHz, CDCl3): δ 2.29 (s, 6H), 2.56–2.63 (m,
1H), 2.75–2.83 (m, 3H), 3.34–3.45 (m, 1H), 3.50–3.57 (m, 1H),
4.09–4.30 (m, 1H), 7.00–7.03 (m, 3H)
13C NMR (126 MHz, CDCl3): δ 19.5, 21.2, 37.2, 43.0, 103.4,
126.4, 127.9, 132.2, 136.3, 136.7, 140.6, 198.0.
MS (ESI): m/z 215.2 [M-H]−
2-diazo-5-(2,4-dimethylphenyl)cyclohexane-1,3-dione (3)
(Presset et al., 2011).
To a solution of 2 (100 mg, 0.46 mmol, 1 eq) in acetonitrile
(10 ml) was added a solution of p-toluenesulfonylazide (13%
in toluene; 785 µl, 0.46 mmol, 1 eq) and K2CO3 (76 mg,
0.55 mmol, 1.2 eq). The mixture was protected from light
and stirred overnight at room temperature. The mixture was
then concentrated and the compound was extracted with
dichloromethane (3∗50 ml). The combined organic layers were
dried over magnesium sulfate, filtered and concentrated under
vacuum. The crude was chromatographed on a silicagel column
with dichloromethane/ethyl acetate (9:1) to afford a white solid
(3) (78.2 mg, 0.32 mmol, 70.3%).
TLC: Rf = 0,76 (dichloromethane/ethyl acetate 8:2, UV and
ninhydrin).
1H NMR (500 MHz, CDCl3): δ 2.27 (s, 3H), 2.28 (s, 3H), 2.63–
2.74 (m, 4H), 3.53–3.58 (m, 1H), 7.00–7.04 (m, 3H).
13C NMR (126 MHz, CDCl3): δ 19.1, 20.8, 32.0, 43.7, 84.3,
124.7, 127.3, 131.8, 135.1, 136.4, 136.7, 189.5.
MS (ESI): m/z 243.11235 [M+H]+
6-(2,4-dimethylphenyl)-2-ethyl-6,7-dihydrobenzo[d]oxazol-
4(5H)-one (ADX71743) (Kallstrom et al., 2004).
To compound 3 (2.02 g, 8.35 mmol, 1 eq) was added
propionitrile (2.3 g, 41.7 mmol, 5 eq) and rhodium (II)-
acetate dimer (6.88 mg, 16.7 µmol, 0.002 eq). The mixture
was heated at 60◦C for 1 h, cooled to room temperature and
the crude was chromatographed on a silicagel column with
dichloromethane/ethyl acetate (98:2) to afford a pale yellow solid
(ADX73741) (994 mg, 3.70 mmol, 44.2%).
TLC: Rf= 0,23 (dichloromethane/ethyl acetate: 9:1, UV).
1H NMR (500 MHz, CDCl3): δ 1.41 (t, J = 7.6 Hz, 3H), 2.29
(s, 3H), 2.31 (s, 3H), 2.72 (dd, J = 16.4 and 3.9 Hz, 1H), 2.84
(d, J = 16.4 Hz, 1H), 2.85 (qu, J = 7.6 Hz, 2H), 3.10–3.13 (m,
2H), 3.83 (m, 1H), 7.06 (s, 1H), 7.07 (d, J = 7.8 Hz, 1H), 7.20
(d, J = 7.8 Hz, 1H).
13C NMR (126 MHz, CDCl3): δ 11.1, 19.4, 21.0, 21.9, 29.5, 36.9,
44.9, 125.5, 127.4, 132.0, 134.3, 135.3, 137.0, 137.1, 163.5, 166.6,
190.5
HRMS calculated for [C17H20O2N]+: 270.14940.
HRMS found for [C17H20O2N]+: 270.14862.
Elementary analysis calculated, %: C 75.81; H 7.11; N 5.20.
Elementary analysis found, %: C 75.18; H 6.95; N 4.36.
HPLC: macherey nagel (125 mm × 4.0 mm, 5 µm). Flow rate:
0.7 ml/min et λ= 254 nm.
Solvent A (water/methanol/HCOOH: 900:100:1) and solvent B
(water/methanol/HCOOH 200:800:1) TR= 19.6 min.
Mice
All animal procedures were conducted in accordance with the
European Communities Council Directive (2010/63/EU) and
approved by the French Ministry for Agriculture. The generation
and characterization of the mutant mice are described elsewhere
(mGluR7aAAA/AAA mouse, herein named mGlu7aAAA mice,
(Zhang et al., 2008).
Acute Thalamocortical Slices
Preparation
All chemicals used to prepare electrophysiological solutions
were purchased from Sigma–Aldrich (France). mGlu7AAA or
WT littermates male and female mice aged P15–P21 were
deeply anesthetized by inhalation of isoflurane, and slices were
prepared with a vibratome (Campden Instruments, UK) as
previously described (350 µm-thick, 35◦ tilt from coronal,
Cruikshank et al., 2007) to preserve the thalamocortical network.
As intra-TRN projections are denser in the horizontal plan, we
prepared 230 µm-thick horizontal slices when studying intra-
TRN synapses. We then incubated slices at 32◦C for 1 h and then
at 24–26◦C, in artificial cerebrospinal fluid (ACSF) containing (in
mM) 120 NaCl, 2.5 KCl, 1.6 NaH2PO4, 1.3 MgCl2, 2.5 CaCl2, 27
NaHCO3, and 22 glucose, equilibrated with 95% O2 and 5% CO2,
pH 7.4.
Whole-Cell Patch-Clamp Recording
Following incubation, brain slices were transferred to the
recording chamber and superfused with ACSF (2 ml/min, 32◦C).
For EPSC recording ACSF was supplemented with D-AP5
(50 µM) and bicuculline (10 µM). For IPSC recording, ACSF
was supplemented with CNQX (10 µM) and D-AP5 (50 µM).
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All drugs were purchased from Tocris (France). Recordings were
obtained from visually identified TRN, VPM, and cortical layer
4 neurons using differential contrast optics with an upright
microscope (Olympus, France) and an infrared CCD video
camera (COHU, SAIS, France). Recording electrodes made of
borosilicate glass had a resistance of 4–7 M when filled
with intracellular solution. For thalamic neurons, the internal
solution contained (in mM) 115 CsMeSO3, 20 CsCl, 10 HEPES,
0.6 EGTA, 4 Na2-ATP, 0.4 Na-GTP, 10 Na-phosphocreatine,
and 2.5 MgCl2. For cortical layer 4 neurons, the internal
solution contained (in mM) 125 K-gluconate, 10 KCl, 10 HEPES,
0.2 EGTA, 4 Na2-ATP, 0.3 Na-GTP, 14 Na-phosphocreatine,
and 1.8 MgCl2. For both solution, pH was adjusted to 7.3
with CsOH or KOH, respectively, and the osmolarity was
300 mOsm. For all recording conditions, only cells with access
resistance < 18 M and a change of resistance < 25%
over the course of the experiment were analyzed. Data were
filtered with a Hum Bug (Quest Scientific, Canada), digitized
at 2 kHz (Digidata 1444A, Molecular Devices, Sunnyvale, CA,
USA), and acquired using Clampex 10.2 software (Molecular
Devices).
Electrical Stimulation of VPM and TRN
Electrical stimulations were delivered via a bipolar stimulation
electrode (0.1–1 mA, 100 µs; FHC Inc.). To study the effect
of the mGlu7 receptor at thalamic presynaptic sites, the
stimulation electrode was placed either in the VPM to evoke
excitatory postsynaptic currents (eEPSCs) in TRN neurons,
held at −60 mV (inward currents), or in the TRN to evoke
inhibitory postsynaptic currents (eIPSCs) within adjacent TRN
neurons or VPM neurons, held at 0 mV (outward currents).
The group III mGluRs agonist D,L-AP4 (1.2 mM, Tocris
Bioscience) and the mGlu7 receptor NAM ADX71743 (10 µM)
were applied and the effects compared between the two
genotypes.
Minimal Evoked Monosynaptic
Responses: Single and Repetitive
Stimulation
For electrical and optogenetical stimulation experiments, single-
stimulation and train-stimuli were applied on slices to activate
small groups of neurons within TC loop regions, and we then
recorded evoked responses in neurons receiving the input.
Immediately after obtaining a whole cell recording, a few test
stimuli were delivered to check the synaptic responsiveness of
the neuron. Once monosynaptic response was clearly observed,
evoked excitatory (eEPSCs) or inhibitory postsynaptic currents
(eIPSCs), respectively, were isolated by switching the perfusion
solution from normal ACSF to one containing drugs (isolation
of AMPA currents with ionotropic GABA and NMDA receptor
blockers, 10 µM bicuculline and 50 µM D-AP5; isolation of
GABA currents with ionotropic glutamate receptor blockers,
10 µM CNQX and 50 µM D-AP5; Tocris Bioscience). After
7 min drugs perfusion, test stimuli of increasing intensity were
applied to determine the minimal excitability threshold evoking
monosynaptic postsynaptic currents. Stimulation vs. amplitude
values for all cell type tested are reported in Supplementary
Figure 1. Averages of 10–20 trials were used to measure the
amplitudes of ePSCs, from baseline to peak.
We also tested the response plasticity by applying five
pulses (0.1–1 mA, 100 µs duration) at 10 Hz, close to natural
whisker-input frequency into the thalamus during exploratory
whisking (Knutsen et al., 2008). Averaged 10 trials of 10 s
inter-trials were used to measure the five peak amplitudes.
Short-term plasticity depends on a presynaptic modulation
of neurotransmitter release, which is reflected postsynaptically
by an increase (synaptic facilitation) or decrease (synaptic
depression) of ePSCs along the stimulation train. Facilitation
and depression ratios were calculated as the percentage of
the response amplitude to pulse 2 to 5 divided by the
response amplitude to the pulse 1. In experiments in which
we added supplementary drugs in the perfusing solution, we
repeated single-stimulation and train-stimuli protocols after
7 min.
Spontaneous Phasic and Tonic GABAA
Currents Recordings
Thalamic reticular nucleus and VPM cells receiving TRN neurons
inputs were voltage-clamped at −60 mV, and GABAA receptor-
mediated currents were pharmacologically isolated with 10 µM
CNQX and 50 µM D-AP5. Miniature IPSCs (mIPSCs) were
obtained by adding 1 µM tetrodotoxin (TTX, Tocris) to block
action potentials. mIPSCs frequency was analyzed and compared
between WT and mGlu7aAAA mice. Tonic GABAA currents were
revealed as a shift in baseline current following the addition of the
GABAA receptor antagonist gabazine (SR-95531, Sigma–Aldrich)
to the perfusing solution.
Optogenetical Stimulation of
Thalamocortical Fibers
Adeno-associated virus carrying cDNA for channelrhodopsin
and the fluorescent reporter mCherry (AAV2/1.CAG.hChR2
(H134R)-mCherry; Karl Deisseroth, Stanford University via the
UPenn VectorCore, PA, USA) were injected into the VPM of WT
or mGlu7AAA mice at post-natal days 13 (stereotaxic coordinates
from olfactive bulb junction were lateral, 2.10 mm; posterior,
4.50 mm; and depth, 3.50 mm). The viral titer was 1011 IU/ml
and injection volume was 0.7 µl. After allowing 4–8 days for
ChR2 expression, acute somatosensory thalamocortical slices
were used for in vitro patch-clamp recording (see above). VPM
synaptic terminals expressing hChR2-mCherry were stimulated
with blue light (LED, 488 nm, 0.1 ms/pulse, 40–200 µW)
shined in the barrel cortex layer IV. Cortical neurons were
identified as excitatory cells, Regular-Spiking (RS) or Fast-
Spiking (FS) interneurons, according to their electrophysiological
properties (see Supplementary Figure 2). In some cases, at the
end of the experiments TC slices were incubated overnight in
phosphate buffer saline solution (PBS) containing 4% PFA at
4◦C and mounted between microscope slides and coverslips
using Mowiol to image the correct localization of virus-induced
expression of hChR2-mCherry with an AxioImager Z1 apotome
and AxioVision software (Carl Zeiss, France).
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Surgery and Electroencephalography
(EEG) Recordings
Wild-type or mGlu7AAA male mice were anesthetized with
2 ml/kg of a saline solution containing 40% (v/v) ketamine
(Imalgene 500) and 20% (v/v) xylazine (Rompun 2%) and placed
in a stereotaxic frame using the David Kopf mouse adaptor.
A male microconnector (Pinnacle Technology Inc., Lawrence,
KS, USA) was fixed by four extradural screws, two on each
parietal bone. The microconnector was then fixed with dental
acrylic cement. After surgery, animals were individually housed
and maintained in a 12 h light/dark cycle with food and water ad
libitum for 1 week of recovery.
For recordings, animals were put into individual Plexiglas
boxes, and their micro connectors were plugged to an
EEG preamplifier circuit and to the EEG amplifier (Pinnacle
Technology Inc., Lawrence, KS, USA). The electrical activity
recorded by extradural electrodes was filtered at 50 Hz, sampled
at 400 Hz and recorded by a computer equipped with Sirenia R©
software (Pinnacle Technology Inc.). A 30 min period of baseline
recording before ADX71743 injection (i.p.; volume of injection:
100 µl/10 g mouse weight of a 100 mg/kg suspension in 50% v/v
H20 and hydroxyl-propyl-β-cyclodextrin) allowed detection of
EEG abnormalities independent of experimental manipulations.
Control animals were injected with vehicle alone. EEG recordings
were performed together with monitoring animal behavior.
The symptoms developing after injection were classified into
different phases as described by (Weiergraber et al., 2006)):
phase 0 corresponds to normal exploration and posture; phase
1 corresponds to an “absence-like” non-convulsive state, with
reduced motility and typical prostrated position of the animal;
phase 2 shows partial clonus of head, vibrissae and/or forelimbs;
phase 3 consists of a generalized clonus of the extremities, the
tail, and sometimes vocalization; this phase can develop into
typical “running fits”; phase 4 corresponds to a generalized
tonic-clonic seizure with extension of the four paws; this phase
is occasionally followed by death by respiratory failure. We
defined “lethargy” as a continuous period of immobility or
slow movement of the mouse limited to less than one body-
length of the mouse. Observations were made by a blind
observer.
HEK293 Transfection
In order to enhance the read-out of our pharmacological tests,
we used the chimeric Gq/io protein that is able to bind all GPCRs
(GqTOP). Stimulation of the mGlu7/GqTOP pathway activates
phospholipase C (PLC), which hydrolyzes phosphatidylinositol
bisphosphate (PIP2) to form two second messengers, inositol
1,4,5-triphosphate (IP3) and diacylglycerol (DAG). IP3 is very
rapidly hydrolyzed to IP2 then to IP1, and finally to inositol
by a series of enzymatic reactions (Berridge and Taylor, 1988)
blocked by lithium chloride (LiCl; Garbison et al., 2012). HEK293
cells were transfected by electroporation (250 V–500 µF for
5.106 cells) with plasmids expressing the GqTOP protein and the
glutamate transporter EAAC1, associated with vehicle plasmids
(control, MOCK) or mGlu7a-expressing plasmid (Perroy et al.,
2000). Cells were plated at 150,000 per well (each condition
in triplicate) in 96-well sterile, black microplates in DMEM
supplemented with 10% FCS. After 24 h, DMEM medium
was replaced by GlutamaxTM (GIBCO, Thermo Fisher, France)
2 h before performing TR-FRET experiments. Notice that
the expression of EAAC1 as well as GlutamaxTM allowed
obtaining a minimal glutamate extracellular concentration, to
avoid glutamate-mediated activation of mGlu7a receptors.
Inositol Phosphate 1 Measurement by
Time-Resolved Fluorescence Resonance
Energy Transfer (TR-FRET) Assay
The production of IP1 by HEK293 cells was tested using
TR-FRET assays, based on Time-Resolved Resonance Energy
Transfer. TR-FRET assays were performed in presence of LiCl
to block IP1 degradation, using anti-IP1 mouse antibody labeled
with Terbium cryptate-conjugate (Tb, Tb-Ab) that will be the
donor of energy, and d2-conjugated IP1 (d2, d2-IP1) that will
be the acceptor of energy (Cisbio Bioassays, France). After
30 min incubation at 37◦C with stimulation buffer alone (
Base ) or supplemented with a group III mGluRs agonist (L-
AP4, 600 µM) or antagonist (CPPG, 100 µM, Tocris Bioscience,
France) or the mGlu7-specific NAM ADX71743 (10 µM), d2-
IP1 acceptor and Tb-Ab donor were added and cells incubated
for 1 h at room temperature. The anti-IP1 antibody competes
with native IP1 produced by cells and D2-labeled IP1 from the
kit. The fluorescence of Tb and d2 were measured, respectively,
at 620 and 665 nm (after 50 µs delay) and divided by the
337 nm excitation signal using a RUBYstar plate reader (BMG,
Germany). The resulting signal is inversely proportional to
the concentration of IP1 in samples, determined by using a
standard curve construction, since the donor–acceptor pair
gives a high transfer of energy signal that decreases upon
competition with IP1 produced by the cells (Garbison et al.,
2012).
Data Analysis
Whole-cell recordings were analyzed using Clampfit 10.2
software (Molecular Devices). Response amplitudes, short-term
plasticity ratios, mIPSCs properties and tonic current amplitudes
were compared between WT and mGlu7aAAA mice using the
Mann-Whitney test or repeated measures ANOVA (∗P < 0.05,
∗∗P < 0.01, ∗∗∗P < 0.001). Normalized IP1 concentrations
obtained from TR-FRET experiments were compared using an
unpaired t-student test (∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001). All
averaged data are presented as mean± SEM.
Eelectroencephalography signals were analyzed using Matlab
2013b software (Matworks Inc.). Short time Fourier transform
analysis was realized using the Signal Processing toolbox
(Spectrogram function) and applied to the EEG data in order to
obtain the energy of the signal as a function of frequency and time
(Freeman and Quiroga, 2013). Bartlett-type window was used to
avoid leakage.
We extracted a qualitative measure for each of the EEG
frequency bands i (i = δ, θ, α, β, γ), where δ = 2 – 4 Hz, θ = 4 –
8 Hz, α = 8 – 14 Hz, β = 14 – 30 Hz, and γ = 30 – 70. This
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I(f , t)dfi = δ, θ, α, β, γ (1)
where (f imin, f
i
max) are the frequency limits for the band i, and I(f,t)
is the power spectrum as a function of frequency f and time t.
The time windows used 256 points (0.64 s at a sampling rate of
400 Hz).
RESULTS
Modulation of Glutamatergic Thalamic
Synapses by mGlu7a Receptor
PDZ-Dependent Signaling
We aimed at identifying the thalamic synapses functionally
expressing mGlu7a receptors, by comparing the response of WT
mice to mGlu7aAAA mice, which are deficient in controlling
neurotransmitter release (Zhang et al., 2008).
Intra-thalamic transmission properties were first tested by
electrically stimulating VPM neurons and recording evoked
excitatory postsynaptic currents (EPSCs) in the TRN on in vitro
TC slices (Figure 1B). Neurons from mGlu7aAAA mice showed
smaller EPSCs than WT neurons (WT: −124.3 ± 17.9 pA,
n = 48; mGlu7aAAA: −68.0 ± 15.2 pA, n = 28, p = 0.050;
Figure 1C). This observation was not due to a change in input
resistance, which was similar in WT and mGlu7aAAA TRN
neurons (261 ± 90 MOhm for WT, 272 ± 43 MOhm for
mGlu7aAAA, p = 0.9088). The non-selective mGlu7 receptor
agonist, D,L-AP4 (1.2 mM), induced the inhibition of evoked
EPSC. This was significantly smaller in mGlu7aAAA (32.6± 5.3%,
n = 15) than in WT neurons (53.0 ± 3.8%, n = 32; p = 0.0034;
Figures 1D,E). The difference between the two values represents
the mGlu7a-PDZ ligand-dependent pathway activation. The
residual inhibition induced by D,L-AP4 likely resulted from
action of the drug on mGlu4 and/or mGlu8 receptors, or PDZ
ligand-independent mGlu7 receptor signaling. This applies to
all the synapses we will analyze in the following experiments.
Analysis of amplitude response as a function of stimulation
intensity is given in Supplementary Figure 1. For neurons
requiring low stimulation intensity, the responses of WT and
mGlu7aAAA synapses were similar, suggesting that the properties
of postsynaptic receptors are not involved. However, for neurons
requiring higher stimulation intensities, which require more
available vesicles, WT synapses respond more strongly than
mGlu7aAAA synapses, suggesting that the pool of vesicles in
the mGlu7aAAA neurons is limiting. This is in keeping with a
greater proportion of neurons presenting a facilitating response
in mGlu7aAAA VPM to TRN synapses, as smaller initial responses
have a greater potential to facilitate (see for example Zucker
and Regehr, 2002). Another possibility is that a lower number
of fibers is recruited upon stimulation in mGlu7aAAA mice
as a consequence of developmental modifications of network
excitability.
We also found that eEPSCs were increased by the negative
allosteric mGlu7 modulator (NAM) ADX71743 (10 µM) in WT
mice (31.2 ± 9.8%; n = 15), highlighting a tonic activity of the
receptor. The effect of the NAM was much smaller in mGlu7aAAA
mice (1.9± 9.2%; n= 13; p= 0.0111; Figures 1F,G). These results
suggest the existence of an mGlu7a receptor PDZ-dependent
inhibition of glutamatergic VPM projections within the TRN in
WT mice.
As previously described (Mistry et al., 2008), a 10 Hz 5-pulse
stimulation protocol applied to VPM-TRN synapses induced
either synaptic depression or synaptic facilitation, in both WT
and mGlu7aAAA mice (Figure 2). Depression ratios were non-
significantly modified in mutant mice (Figures 2A,B), while
facilitation ratios were significantly higher compared to WT
mice (Figures 2C,D). Moreover, the proportion of neurons
showing a facilitating response was significantly increased in
mGlu7aAAA mice (Figure 2E). These data indicate that an
active mGlu7a receptor PDZ-dependent pathway promotes
the low-pass filtering of information from the VPM to
the TRN by increasing synaptic depression and lessening
facilitation in basal conditions. Interestingly, treatment with
ADX7173 did not change the short-term plasticity (data not
shown), likely a consequence of a long-term absence of
mGlu7a C-terminal signaling. The lower EPSCs amplitudes in
mGlu7aAAA mice seen in Figure 1C might reflect presynaptic
fatigue due to the over-excitation of synaptic terminals. The
tonic activity of mGlu7a receptors might lead to an inhibition
of voltage-gated calcium channels, which would decrease Ca2+
entry into WT synapse terminals. Another possibility would
be that postsynaptic glutamate receptors desensitize upon
sustained activation. This would be consistent with our results
showing that the synaptic facilitation is favored and depression
is reduced in mutant mice, in the absence of exogenous
agonists.
Modulation of GABAergic Synaptic
Transmission within and from Thalamic
Reticular Neurons by mGlu7 Receptors
Thalamic reticular nucleus neurons innervate adjacent reticular
neurons as well as VPM neurons and constitute the only
inhibitory input in these two nuclei in mice (Pinault and
Deschenes, 1998). We investigated the synaptic function of
the mGlu7 receptor on synaptic transmission and short-term
plasticity by electrically stimulating TRN neurons, and recording
the evoked IPSCs into either TRN or VPM nuclei in TC slices
(Figures 3 and 4).
Amplitudes of intra-TRN IPSCs evoked by single stimulations
were similar in WT and mGlu7aAAA slices (Figure 3B). D,L-AP4
inhibited intra-TRN evoked IPSCs and this effect was reduced in
mGlu7aAAA mice (14.7± 2.6%, n= 21) as compared to WT mice
(31.6 ± 3.6%, n = 23; p < 0.001; Figures 3C,D). Interestingly,
we found that the amplitudes of eIPSCs were increased by
ADX71743 in WT mice (31.2 ± 9.7%; n = 12). In this context
the contribution of endogenous glutamate release to activation
of the receptor should be limited, suggesting that the mGlu7
receptor constitutively inhibits GABA release by TRN neurons.
Conversely, the effect of the NAM was minimal in mGlu7AAA
mice (0.56± 10.8%; n= 13; p= 0.0297; Figures 3E,F), implying
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that this constitutive activity is dependent on mGlu7 PDZ ligand-
binding site.
In accordance with previous studies (Reichova and Sherman,
2004), we found that repetitive stimulation induced depression
of intra-TRN evoked IPSCs. This effect was significantly reduced
in mGlu7aAAA mice (Figures 3G,H), thus reflecting a reduced
plasticity of GABA synapses.
mGlu7a Receptors Reduce Tonic GABA
Currents in the VPM
At TRN–VPM synapses (Figure 4A), we found that phasic,
D,L-AP4-induced inhibition as well as synaptic depression were
similar in WT and mGlu7aAAA mice (Figures 4C,D), implying a
non-contribution of mGlu7a receptor PDZ-dependent pathway
in the control of those synapses. However, we found that eIPSCs
were smaller in mGlu7aAAA mice (Figure 4B), a phenomenon
that might be due to indirect fatigue following overactivation of
the intra-TRN pathway.
In synthesis, the PDZ-dependent pathway of mGlu7a receptor
modulates evoked inhibitory synaptic transmission only in intra-
TRN, but not in TRN–VPM synapses.
The above results showed that mGlu7a receptors control
evoked synaptic activity in the thalamus. Here, we investigated
whether the mGlu7a receptor could also affect the spontaneous
synaptic activity of reticular neurons. We first examined phasic
FIGURE 1 | The mGlu7 receptor modulates glutamatergic transmission at VPM synapses onto TRN neurons. (A) Schematic representation of the
thalamocortical and intra-thalamic connections between glutamatergic and GABAergic neurons in the somatosensory cortex (S1), the thalamic reticular nucleus
(TRN) composed exclusively of GABAergic neurons, and the ventro-postero-medial nucleus (VPM), devoid of interneurons. FS, Fast-Spiking interneurons; RS,
Regular-Spiking interneurons; Exc, excitatory glutamatergic neurons. (B) Experimental configuration, including the positions of the electrical stimulation into the VPM
and the recording electrode into the TRN. (C) Single and average amplitudes of evoked EPSCs in WT and mGlu7aAAA mice. (D,F) Representative evoked EPSCs
recorded from TRN neurons in response to VPM stimulation of WT (left) and mGlu7aAAA (right) mice and effect of D,L-AP4 (1.2 mM, D) and ADX71743 (10 µM, F).
Black arrows indicate electrical stimulations. (E) Summary of D,L-AP4-induced inhibition of EPSCs. (G) Summary of ADX71743-induced increase of EPSCs.
∗P < 0.05, ∗∗P < 0.01, Mann-and-Whitney test. Error bars indicate SEM.
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GABAA inhibition in neurons from WT and mGlu7AAA TC
slices. mIPSC were studied in both the TRN and VPM neurons,
which receive GABAergic inputs exclusively from TRN neurons.
The frequency of mIPSCs was higher in both TRN (WT:
1.30 ± 0.10 Hz, n = 12; mGlu7AAA: 3.09 ± 0.27 Hz, n = 14;
p < 0.0001; Figures 5A,B) and VPM neurons (WT: 10.92± 1.23,
n = 18; mGlu7AAA: 18.34 ± 1.05, n = 20; p < 0.0001;
Figures 5D,E) of mGlu7AAA than in WT mice, while mIPSCs
amplitudes were identical in both genotypes (Figures 5C,F).
Enhanced mIPSCs frequency could be due to long-term change
of the release machinery and/or differential presynaptic bouton
handling of calcium levels.
Altogether these results suggest the implication of the mGlu7a
receptor PDZ-dependent pathway in spontaneous GABA release
from TRN neurons.
Synaptically released GABA can also diffuse outside the
synapse and activate extra-synaptic GABAA receptors, leading
to a tonic GABAA current (Mody, 2001) that can be
specifically blocked by gabazine (Cope et al., 2005). Using this
pharmacological tool, we found that tonic GABAA current
amplitude was increased in the VPM of mGluR7aAAA slices (WT:
35.23± 7.96, n= 14; mGlu7aAAA: 60.20± 6.83, n= 18; p< 0.01;
Figures 5G,H), suggesting that extra-synaptic GABA level in the
VPM is higher in mGlu7AAA than in control mice and reinforcing
the idea of an essential basal modulation of TRN activity by the
mGlu7 receptor. Indeed, application of ADX71743 (10 µM) on
WT VPM neurons increased the gabazine-sensitive current to
levels comparable to those found in mGlu7aAAA mice and had
no effect on mGlu7aAAA mice (Figure 5H). These results suggest
that mGlu7 receptors tonically inhibit GABA release on VPM
neurons. Conversely, tonic GABAA current was absent in TRN
neurons of both WT and mGlu7aAAA mice (data not shown),
which is in accordance with the absence of extra-synaptic GABAA
receptors in this nucleus (Jia et al., 2005).
mGlu7 Receptors Depress VPM to
Cortical Layer 4 Fast-spiking Interneuron
Synapses
Thalamic neurons relay sensory information to the barrel
cortex, and VPM axon terminals project predominantly onto
cortical layer 4, where three main classes of neurons are
FIGURE 2 | Short-term synaptic plasticity in VPM to TRN synapses. (A,C) Representative current traces from TRN neurons responding to five stimuli at 10 Hz
(black arrows) in WT (left) and mGlu7AAA (right) mice. VPM afferents display either short-term synaptic depression (A) or facilitation (C) in both genotypes.
(B,D) Short-term synaptic depression ratios show no significant differences between the two genotypes, while facilitation ratios are strongly increased in mGlu7AAA
mice. (E) Proportion of neurons displaying either short-term synaptic depression or facilitation in WT (left) or mGlu7aAAA (right) mice. ∗P < 0.05, Mann-and-Whitney
test. Error bars indicate SEM.
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FIGURE 3 | The mGlu7 receptor modulates GABAergic transmission and short-term synaptic plasticity in intra-TRN synapses. (A) Experimental
configuration, including positions of electrical stimulation into the TRN and recording in adjacent reticular neurons. (B) Evoked IPSC amplitudes show no difference in
responsiveness between WT and mGlu7AAA mice. (C,E) Representative IPSC recorded from TRN neurons in response to TRN single stimulation in WT (left) and
mGlu7aAAA (right) mice before and after application of D,L-AP4 (C) or ADX71743 (E). Black arrows indicate electrical stimulations. (D) D,L-AP4-induced IPSC
inhibition. (F) ADX71743-induced EPSC increase. (G) Representative traces in response to 5 × 10 Hz stimuli and (H) short-term synaptic depression ratios.
∗P < 0.05, ∗∗∗P < 0.001, Mann-and-Whitney test. Error bars indicate SEM.
found: glutamatergic neurons (i.e., pyramidal and spiny stellate
neurons), and the RS and FS GABAergic interneurons. They are
so-called on the basis of their firing pattern in response to current
injection, as confirmed by our characterization (Supplementary
Figure 2).
As thalamo-cortical and cortico-thalamic fibers follow the
same path, we used an optogenetic approach to selectively
stimulate thalamocortical afferents in brain slices (Cruikshank
et al., 2010). Channelrhodopsin 2 (hChR2) was expressed in
VPM neurons by AAV-mediated viral infection and eEPSCs were
induced in cortical layer 4 neurons by shining blue light (488 nm)
in this area (Figure 6A).
The inhibition of evoked EPSCs by D,L-AP4 in FS
interneurons was smaller in mutant mGlu7aAAA than in
WT mice (26.4± 3.4% vs. 39.0± 3.5%; p= 0.023; Figures 6B,C).
VPM-FS synapses showed depression upon repetitive stimulation
(Figures 6D,E), as described in previous studies (Cruikshank
et al., 2010), but depression ratios were significantly smaller in
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FIGURE 4 | The mGlu7 receptors modulate TRN neurons-mediated tonic GABAA inhibition in the VPM. (A) Experimental configuration, including positions
of recording electrode into the VPM and electrical stimulus on TRN. (B) Single and average IPSC amplitudes in WT and mGlu7aAAA mice. (C,E) Representative IPSC
traces from VPM neurons responding to TRN single (C) or 5 × 10 Hz (E) stimulation of WT (left) and mGlu7aAAA (right) mice. Black arrows indicate electrical
stimulations. (D,F) D,L-AP4-induced IPSC inhibition and short-term synaptic depression ratios are similar in both genotypes. ∗∗P < 0.01, Mann-and-Whitney test.
Error bars indicate SEM.
mGlu7aAAA than in control mice FS interneurons. These data
suggest a regulation of cortical layer 4 FS interneuron activity by
VPM afferents involving an mGlu7a receptor PDZ-dependent
pathway.
We then investigated the effects of negative allosteric
modulation of the mGlu7 receptor-mediated inhibition of FS
interneurons EPSCs in TC slices from WT mice. ADX71743
increased FS interneuron EPSC amplitude evoked by single
stimulation of VPM axons (Figures 6F,G).
On the contrary, inhibition of single evoked EPSCs as
well as synaptic depression ratio upon repetitive VPM afferent
stimulations (Figures 6H,I) recorded from cortical layer 4
glutamatergic neurons and RS interneurons were similar in
both mice genotypes. Taken together, these results indicate an
mGlu7a receptor PDZ dependent-pathway mediated inhibition
of VPM glutamatergic contacts innervating cortical layer 4 FS
interneurons, but not other studied cortical cell types. They also
suggest that mGlu7 receptors tonically inhibit excitation of FS
interneurons by VPM afferents.
Potential Constitutive Activity of mGlu7
Receptors
The lack of mGlu7-specific orthosteric antagonist prevented us
to definitively conclude on whether mGlu7 has a constitutive,
agonist-independent activity in acute TC slices. Nevertheless
we investigated whether the mGlu7 receptor NAM ADX71743
displayed a true inverse agonist activity in the virtual absence
of glutamate. Inverse agonists are a class of pharmacological
compounds that block receptor constitutive activity. We
transfected HEK cells with different amounts of mGlu7a receptor
cDNA and measured receptor activity as inositol production
by using a chimeric G protein-based time-resolved FRET
assay (TR-FRET, see Section “Materials and Methods” for
details). Importantly, co-transfection of the excitatory amino-
acid transporter EAAC1 allowed lowering the extracellular
glutamate concentration to a sub-micromolar range, unable
to activate mGlu7a receptors (P. Rondard, IGF Montpellier,
personal communication). We remarked a higher receptor
activity as compared to the control transfection, which was
increasingly proportional to the quantity of mGlu7a receptor
expressed (Figure 7A). This suggested a constitutive activity
of the recombinant receptor. We then compared the effect of
the orthosteric non-selective mGlu7a receptor agonist L-AP4
(600 µM), and antagonist CPPG (100 µM), as well as the
selective mGlu7 receptor NAM ADX71743 (10 µM) on the
production of inositol phosphates (IP) in mGlu7a receptor-
transfected HEK cells (Figure 7B). In mGlu7a-transfected cells,
IP1 production increased in the presence of L-AP4, confirming
that the recombinant receptor was functionally expressed in
HEK cells. The basal production of IP1 in HEK cells expressing
mGlu7a receptors was not modified by CPPG, as expected from
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FIGURE 5 | The mGlu7a receptor decreases TRN neurons-mediated tonic and phasic GABAA inhibition in VPM and TRN. (A) Representative current
traces of spontaneous mIPSCs recorded from WT and mGlu7AAA TRN neurons in the presence of TTX (1 µM). (B,C) Mean mIPSCs frequency (B) and amplitude (C)
in TRN neurons. (D,E,F) Same legend as in (A–C), respectively, in VPM neurons. (G) Example traces of tonic GABAA current recorded in WT and mGlu7AAA TRN
neurons upon application of 50 µM gabazine (top traces, black and blue) or gabazine plus ADX71743 (10 µM, bottom traces, orange and red). The baseline shift
reflects the inhibition of tonic GABAA current. (H) Average tonic GABAA current amplitude in WT and mGlu7AAA neurons with and without co-application of
ADX71743 (10 µM). ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, Mann-and-Whitney test. Error bars indicate SEM.
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FIGURE 6 | The mGlu7 receptor modulates glutamatergic transmission between VPM neurons and cortical layer 4 Fast-Spiking interneurons.
(A) Experimental configuration and example of a thalamocortical slice expressing hChR2-mCherry in VPM thalamic neurons and their axons targeting cortical layer 4.
LED stimuli (blue light, 488 nm) were directed on layer 4 thalamocortical hChR2-expressing terminals where postsynaptic responses of cortical neurons were
recorded. (B,D) Representative current traces recorded from a Fast-Spiking interneuron in response to VPM single (B) or 5 × 10 Hz (D) stimulations, in WT (left) and
mGlu7aAAA (right) mice. Blue arrows indicate light stimulations. (C) D,L-AP4-induced EPSC amplitude inhibition (n = 17 for WT, n = 19 for mGlu7aAAA mice).
(E) Synaptic depression ratios in WT (left) and mGlu7aAAA mice. Please note the decrease in synaptic depression in the mGlu7AAA mice. (F) Representative current
traces showing the increase in EPSC by ADX71743. (G) Summary of the effects of ADX71743 (10 µM) on EPSCs. (H,I) Average EPSC inhibition induced by D,L-AP4
and short-term synaptic depression ratios in excitatory neurons and Regular-Spiking interneurons, respectively. Please note the absence of difference between WT
and mGlu7aAAA mice. ∗P < 0.05, Mann-and-Whitney test. Error bars indicate SEM.
a classical orthosteric antagonist in the absence of agonist. On
the contrary, ADX71743 inhibited basal IP1 production in the
absence of agonist, likely resulting from constitutive activity of
the recombinant mGlu7a receptor.
In Vivo Induction of Absence Epileptic
Seizures and Lethargy by the mGlu7
Receptor Inverse Agonist
What is the physiological role of the mGlu7 receptor tonic
activity? We examined this issue in vivo by comparing
the effects of ADX71743 (100 mg/kg i.p.) or vehicle alone
(β-cyclodextrin, CD) on brain activity and behavior in WT
and mGlu7aAAA mice, where neurotransmitter release inhibition
mediated by mGlu7a receptor is lost. CD-injected (control)
mice continued normal exploratory activity and grooming,
and showed no modification of their EEG pattern. The
majority of WT mice (31 out of 36 mice) injected with
ADX71743 showed a net decrease in exploratory activity and
reactivity, entering a phase of prostration (Figure 8A). Such
a lethargic status appeared 5 ± 0.5 min after injection and
lasted 43.8 ± 3.7 min (Figure 8G). The mGlu7aAAA mutant
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FIGURE 7 | Constitutive activity of mGlu7a receptors in the absence of extracellular glutamate. (A) Normalized IP1 production in HEK cells transfected or
not (Mock) with increasing amount of mGlu7a receptor cDNA (n = 3). Note that transfection of mGlu7a receptor in the absence of agonist induces IP1 synthesis.
(B) IP1 formation measured in the absence (Base) and presence of the indicated compounds in HEK cells transfected with either wild-type (WT) or a control empty
vector (n = 5). ∗P < 0.05, ∗∗∗P < 0.001, Mann-and-Whitney test. Error bars indicate SEM.
mice showed the typical absence-like behavior with repeated
episodes of exploratory activity arrest and facial myoclonus
previously reported (Bertaso et al., 2008). Administration of
ADX71743 did not worsen this phenotype (31 out of 32,
Figure 8A).
The analysis of EEG in WT mice treated with the ADX71743
revealed an increase in the power of the 0–4 Hz delta band
and 4–8 theta band (Niedermeyer and Lopes Da Silva, 1993),
with appearance of slow-wave spindles (2–8 Hz) with recurrent
spikes typical of K-complexes of non-REM sleep compared
to control mice (Figures 8B,D, n = 21 mice). In four cases
out of 21, on top of the described sleep-related activity,
we observed SWD with an intrinsic frequency of 8–10 Hz
(Figure 8C), similar to those spontaneously arising in non-
treated mGlu7aAAA mice (Figure 8E and Bertaso et al., 2008).
Administration of ADX71743 to mGlu7aAAA mice did not
increase the shape, number or duration of SWD (Figure 8F).
More details on frequency band analysis can be found in
Supplementary Figure 3. These data show that pharmacological
blockade of mGlu7 receptor tonic activity in vivo induces a
lethargic state accompanied by abnormal sleep-related behavior
and absence epileptic seizures.
DISCUSSION
Despite its wide distribution and conservation among species
(Flor et al., 1997; Kinoshita et al., 1998), the function of
mGlu7 receptor in the brain remains poorly understood. The
homology with the other mGluRs has to date hindered the
design of type-specific orthosteric agonists and antagonists. Here,
we took advantage of the combination of a genetic mouse
model and a new inverse agonist to challenge the classical view
of mGlu7 as a receptor exclusively activated when glutamate
concentration rises high. Our results show that mGlu7 receptors
are functionally expressed at synapses formed onto and between
TRN neurons, as well as VPM synapses onto fast-spiking
interneurons of the somatosensory cortical layer 4. We uncover
the modulation of the tonic GABA current by mGlu7 receptors
in TRN synapses. Furthermore, we demonstrate the involvement
of the mGlu7a receptor PDZ-dependent pathway in short-term
plasticity enhancement, reinforcing depression, and reducing
facilitation in WT mice. Mutation of the C-terminal PDZ ligand
motif changes the balance between facilitation and depression
in synapses onto TRN neurons and cortical FS interneurons in
mGlu7aAAA mice, an effect that might result from the long-
term absence of mGlu7 in the TC network. Previous work has
shown that expression of the closely related mGlu4 receptor is
not changed in the mGlu7aAAA mouse, nor is the localization of
mGlu7 (Zhang et al., 2008). However, the results were not specific
to the thalamocortical circuit. Also, the possibility that other
proteins involved in the mGlu7/PICK1 signaling pathway (e.g.,
vesicular proteins, calcium channels) may be changed warrants
further investigation.
These data suggest that the receptor exerts a tonic modulation
of basal synaptic transmission by constantly and specifically
shaping low frequency excitatory and inhibitory postsynaptic
responses. This novel mode of action of the receptor takes place
in near-physiological conditions, in addition to its classical low-
pass filter action during enhanced synaptic activity. The receptor
modulates both GABAergic and glutamatergic transmission in
the thalamus, and its inhibition has consequences on animal
behavior.
ADX71743 Reveals the Potential
Constitutive Activity of the mGlu7
Receptor
Our work indicates that endogenous WT mGlu7 receptors
are tonically active. Due to the limitations brought by the
available pharmacology we cannot exclude a contribution of
elicited glutamate release to the activity of the receptor. However,
we may deduce that at least part of the effect was due to
an agonist-independent activity. Several arguments favor the
existence of a constitutive activity of mGlu7. First, our results
in HEK cells show that, in an isolated system where the
receptor expression and glutamate concentration are tightly
controlled, mGlu7 receptors can act in an agonist-independent
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FIGURE 8 | EEG activity induced by treatment with the mGlu7 receptor NAM. (A) Behavioral response of mice WT and mGlu7AAA mice treated with the either
vehicle or mGlu7 NAM (100 mg/kg i.p.) represented as percentage of total animals tested (n for each score group is indicated on the histogram bars). The scoring
scale is given on the right. (B–F) Example of EEG traces and corresponding short-time Fourier transform representation (frequency over time) are shown for WT mice
injected with either the vehicle alone (B) or the mGlu7 NAM (C,D) and for representative mGlu7AAA mice showing spontaneous SWD when treated with the vehicle
(E) or with the mGlu7 NAM (F). Traces in (C,D) show, respectively, SWD-like and low frequency activity with recurrent spikes corresponding to K-complexes. The
level of wavelet power is represented using the color scale. (G) Latency and duration of the lethargic state observed in WT mice upon ADX71743 administration.
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FIGURE 9 | Summary of findings on functional expression of mGlu7 receptors in the thalamocortical network and alterations brought by the loss of
mGlu7 constitutive activity or by the mGlu7aAAA mutation.
manner. Furthermore, the glutamate concentration in GABA
synapses is bound to be well below the EC50 of mGlu7
receptors (500 µM–1 mM, Schoepp et al., 1999) and yet mGlu7
responded to the application of the NAM in the TRN (phasic
current) and VPM (tonic current). Interestingly, Turner and
Salt (1999) showed that two orthosteric mGluR antagonists,
MAP4 (acting on mGlu4, mGlu7, and mGlu8) and LY341495
(acting on mGlu2, mGlu3, mGlu4, mGlu7, and mGlu8), had
no effect on evoked EPSP amplitude in thalamocortical slices,
suggesting the absence of endogenous glutamate-dependent
activity. We previously proposed the existence of a tonic mGlu7a
receptor-mediated inhibition of voltage-gated calcium channels
in cultured cerebellar granule cells, antagonized by binding of
the protein kinase C substrate MacMARCKS to the receptor
C-terminal tail (Bertaso et al., 2006). Recent data in dissociated
superior cervical ganglia neurons showed that transfection of
mGlu7a receptor is sufficient to induce spontaneous receptor
intracellular signaling, and to inhibit voltage-dependent calcium
channels (Kammermeier, 2015). However, the inverse agonist
used in the study, MMPIP, seems to have a different effect
depending on the cellular context (Niswender et al., 2010). The
future discovery of a true, mGlu7-specific negative orthosteric
antagonist will allow to confirm these results in a clear-cut way.
Tonically Active mGlu7a Receptors as
Gatekeepers against Aberrant TC
Oscillations
What could be the physiological role of the mGlu7a receptor
PDZ-dependent tonic activity? Genetic mouse models allowed a
deeper understanding of the mGlu7 receptor synaptic functions.
For example, the mGlu7 receptor KO and mGlu7aAAA KI mice
display different phenotypes (Sansig et al., 2001; Zhang et al.,
2008), suggesting specific synaptic functions of mGlu7a receptor
PDZ-dependent pathway. We found that in the TC network,
mGlu7a receptor-expressing synapses display higher short-term
synaptic depression than mGlu7aAAA mutant synapses. Pelkey
et al. (2008) showed that the combination of mGlu7a receptor
activation and mossy fibers high frequency stimulation induces
a PICK1-dependent long-term depression in hippocampus. It
thus appears that the mGlu7a receptor-PDZ ligand signaling
participates in both short-term and long-term plasticity, the
neural basis of many cognitive and emotional processes
(O’Connor et al., 2010). The PDZ interaction of mGlu7a with
PICK1 is required for the receptor intracellular signaling, which
could explain these effects, but whether or not control of the
receptor tonic activity by PDZ interaction is required remains
open.
Our data suggest an excessive activation of VPM → TRN,
VPM → cortical layer 4 FS interneurons and intra-TRN
synapses in mGlu7AAA mice, with several consequences on
thalamocortical network physiology. A tentative hypothesis is
that such a tonic modulation of synaptic activities probably
results from tonic activity of mGlu7 receptors. This may
have the following consequences on the TC network functions
(summarized in Figure 9):
(1) Over-activation of the TRN neurons by VPM should
induce hyper-excitation of reticular neurons, and increase
the inhibitory feedback of reticular neurons toward VPM
nucleus via a recurrent pathway. This effect is amplified
by the reticular neurons-mediated spontaneous phasic
and tonic hyper-inhibition of thalamic cells. Interestingly,
increased TRN neurons-mediated tonic inhibition has been
observed in all the other absence epilepsy models (Cope and
Di Giovanni, 2009). Hyperpolarization of VPM neurons is
able to switch their firing pattern from tonic to burst mode,
typically observed during absence seizures (Huguenard
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and McCormick, 2007). This would be more likely in
mGlu7aAAA as opposed to WT mice, where tonic activity of
mGlu7 would provide a permanent control of those bursts.
(2) Intra-TRN inhibition is able to desynchronize reticular
neurons activity (Beenhakker and Huguenard, 2009).
Our results show that intra-TRN inhibition is increased
in the young mGlu7aAAA mice used in the present
studied. This effect mediated by mGlu7a receptor PDZ
interaction should therefore prevent synchronization
of the TRN neurons and protect against absence
seizures. Intra-TRN connections are known to slowly
disappear during cerebral maturation in mice (Pinault,
2004). Therefore this protective effect would be lost
in adult mice, which may support the difference in
the age at which absence seizures appear in rodent
models compared to human (Crunelli and Leresche,
2002).
(3) Layer 4 FS interneurons are known to mediate fast and
powerful perisomatic IPSCs, and are responsible for
the main feed-forward inhibition in the TC network
(Porter et al., 2001; Cruikshank et al., 2007). Our
experiments in mGlu7aAAA TC slices suggest that mGlu7
receptor would prevent over-activation of VPM-FS
interneuron synapses in cortical layer 4, and hyper-
synchronization mediated by these interneurons (Swadlow
et al., 1998).
(4) Several studies have highlighted the impact of tonic GABAA
current on the control of neuronal excitability, with
implications in different pathologies such as epilepsies,
stress or depression-related paradigms (Glykys and Mody,
2007). We demonstrate here a negative feedback provided
by the mGlu7 receptor on tonic thalamic GABAA current.
Similarly, Errington et al. (2011) showed an inhibition of
the tonic GABAA current by mGlu receptors in thalamic
neurons, but the concentrations of L-AP4 used in the
study were too low to fully activate the mGlu7 receptor
subtype. Given the low affinity of the receptor for glutamate,
it is possible that in physiological conditions the mGlu7
receptor acts mainly via its tonic rather than phasic
agonist-dependent activity, at least at GABAergic synapses
where the concentration of glutamate is expected to be
low.
All these data highlight the fact that the physiological
function of the mGlu7 receptor seems of particular importance
to modulate inputs onto GABAergic neurons. The phenotypic
abnormalities found in mGlu7 receptor mutant models reflect
the strength of these synaptic controls in WT CNS. It
is also interesting to underline the emerging concept that
mGlu7 is capable to inhibit synaptic transmission in a
target-specific manner, as shown by the differential effect
on synapses harboring from VPM neurons to either the
cortical layer 4 excitatory neurons (no effect of mGlu7)
or FS interneurons (inhibition). Interestingly, synapse-specific
expression of mGlu7 has been found in hippocampal CA1
synapses onto interneurons expressing a postsynaptic protein,
Elfn1 (Tomioka et al., 2014). Recently, Klar et al. (2015)
have found that mGlu7 receptors control the feed-forward
inhibition onto CA1 pyramidal neurons, acting on GABAergic
parvalbumin-expressing presynapses. Incidentally, the lack of
mGlu7-dependent inhibition observed in the VPM is in
agreement with previous immunohistochemical data showing the
absence of mGlu7 receptor in mouse VPM (Kinoshita et al.,
1998).
An interesting question is raised by the consistently smaller
response in some mGlu7aAAA synapses compared to WT.
These synapses displayed high EPSC or IPSC amplitudes
(>50 pA) in WT mice, while no difference was observed in
intra-TRN low amplitude postsynaptic currents. This could
reflect a variety of mechanisms. First, the lack of mGlu7
receptor-mediated voltage-dependent Ca2+ channels inhibition
in mutant mice might induce a sustained glutamate and
GABA release by VPM and TRN axon terminals, respectively.
Indeed, we showed that spontaneous GABA release by
TRN neurons is increased in mutant mice. As TRN and
cortical L4 neurons receive other glutamatergic inputs in
addition to VPM afferents, we could not examine the VPM
neuron spontaneous activity. Ca2+ accumulation into mGlu7
receptor-expressing axon terminals may also induce higher
facilitation and decreased depression, as observed in mutant
mice synapses. These effects might deplete the releasable
pool of neurotransmitter in presynaptic sites, leading to
a synaptic depression. Alternative explanations could be
the internalization of postsynaptic receptors after sustained
neurotransmitter release or a decrease in thalamic fiber
excitability.
mGlu7 Receptors at the Borders of Sleep
and Epilepsy
A few studies have highlighted the link of mGlu receptors
with absence seizures (Snead and Banerjee, 2000; Bertaso et al.,
2008). In vivo administration of ADX71743 enhanced thalamic
oscillations in association with drowsiness and behavioral arrest
in WT mice. In vitro activation of mGlu7 by L-AP4 in rats reduces
spindle oscillations, which typically occur during the early stage
of sleep or during active phases of slow-wave-sleep oscillations
(Kyuyoung and Huguenard, 2014).
As both sleep and absence seizures are supported by reciprocal
connections between glutamatergic VPM and GABAergic TRN
neurons, and somatosensory cortex (Steriade, 2006; Huguenard
and McCormick, 2007), our data suggest that tonic activity
of the mGlu7 receptor prevents unbalanced activity of the
network that would lead to abnormal sleep-related behavior
or seizures. The border between the lethargic effect and
absence seizures seems blurry, as in a few animals the EEG
revealed SWDs typical of epileptic seizures. The lack of effect
of ADX71743 in mGlu7aAAA mice suggests the PDZ ligand-
dependent tonic activity as essential for receptor functions.
Alternatively, one could imagine an occlusion mechanism
between the mutation of the receptor PDZ ligand motif and the
action of ADX71743.
Frontiers in Neural Circuits | www.frontiersin.org 16 April 2016 | Volume 10 | Article 31
fncir-10-00031 April 21, 2016 Time: 15:22 # 17
Tassin et al. mGlu7 Modulates the Thalamic Network
Overall, it appears that the mGlu7 receptor modulates the
global thalamic state of excitability, reducing its propensity to
switch from the tonic to the oscillatory mode.
In human, GRM7 gene polymorphisms have recently been
associated with autism (Yang and Pan, 2013), schizophrenia
(Ohtsuki et al., 2008), attention deficits and hyperactivity (Park
et al., 2013), age-dependent auditive deficits (Friedman et al.,
2009), although not yet to epilepsies (Goodwin et al., 2000). By
acting directly at crucial nodes of oscillatory networks, the mGlu7
receptor could provide a new therapeutic target against epilepsies,
and more generally neuropathologies resulting from unbalanced
excitation/inhibition inputs.
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